Colgate-Palmolive (NYSE:CL) Price Target Cut to $83.00 by Analysts at Wells Fargo & Company

Colgate-Palmolive (NYSE:CL) had its target price reduced by stock analysts at Wells Fargo & Company from $92.00 to $83.00 in a report released on Tuesday,Benzinga reports. The firm currently has an “underweight” rating on the stock. Wells Fargo & Company‘s price objective would indicate a potential downside of 5.02% from the company’s current price.

A number of other brokerages have also commented on CL. StockNews.com upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Wednesday, January 1st. Piper Sandler decreased their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday. Stifel Nicolaus cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their price target for the company from $105.00 to $101.00 in a research report on Monday, October 28th. Deutsche Bank Aktiengesellschaft lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and boosted their price objective for the stock from $107.00 to $109.00 in a report on Monday, September 9th. Finally, JPMorgan Chase & Co. raised their target price on Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a report on Friday, October 11th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, Colgate-Palmolive currently has an average rating of “Moderate Buy” and a consensus price target of $103.63.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock opened at $87.39 on Tuesday. The stock has a market capitalization of $71.40 billion, a PE ratio of 25.04, a price-to-earnings-growth ratio of 3.31 and a beta of 0.44. Colgate-Palmolive has a 52 week low of $79.69 and a 52 week high of $109.30. The stock has a 50 day moving average price of $92.89 and a two-hundred day moving average price of $98.23. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04.

Insider Activity

In other news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.34% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in CL. D Orazio & Associates Inc. lifted its stake in shares of Colgate-Palmolive by 3.9% during the 3rd quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock valued at $297,000 after buying an additional 108 shares in the last quarter. Fiducient Advisors LLC lifted its position in shares of Colgate-Palmolive by 5.2% in the third quarter. Fiducient Advisors LLC now owns 2,231 shares of the company’s stock valued at $232,000 after acquiring an additional 110 shares in the last quarter. Wealthspire Advisors LLC boosted its stake in shares of Colgate-Palmolive by 3.0% in the second quarter. Wealthspire Advisors LLC now owns 3,853 shares of the company’s stock worth $374,000 after acquiring an additional 111 shares during the period. Sequoia Financial Advisors LLC grew its position in shares of Colgate-Palmolive by 0.6% during the third quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company’s stock worth $2,117,000 after purchasing an additional 113 shares in the last quarter. Finally, Evernest Financial Advisors LLC raised its stake in Colgate-Palmolive by 4.0% during the 2nd quarter. Evernest Financial Advisors LLC now owns 2,985 shares of the company’s stock valued at $290,000 after purchasing an additional 115 shares during the period. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.